{
    "clinical_study": {
        "@rank": "57066", 
        "acronym": "SOLITAIRE-IV", 
        "arm_group": [
            {
                "arm_group_label": "Moxifloxacin", 
                "arm_group_type": "Active Comparator", 
                "description": "Intravenous with the potential step-down to oral moxifloxacin"
            }, 
            {
                "arm_group_label": "Solithromycin", 
                "arm_group_type": "Experimental", 
                "description": "Intravenous with potential step-down to oral solithromycin"
            }
        ], 
        "brief_summary": {
            "textblock": "This study will evaluate the safety and efficacy of an experimental antibiotic,\n      solithromycin, in the treatment of adult patients with community-acquired pneumonia."
        }, 
        "brief_title": "Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia", 
        "completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Community-acquired Bacterial Pneumonia", 
        "condition_browse": {
            "mesh_term": [
                "Pneumonia, Bacterial", 
                "Pneumonia"
            ]
        }, 
        "detailed_description": {
            "textblock": "Community-acquired bacterial pneumonia (CABP) is an acute infection of the pulmonary\n      parenchyma with symptoms such as fever or hypothermia, chills, rigors, chest pain, and/or\n      dyspnea. The widespread emergence of antibiotic resistant pathogens, including the\n      macrolide-resistant Streptococcus pneumoniae, has resulted in a need for new and effective\n      antibiotics that have activity against CABP pathogens. Solithromycin is a fourth generation\n      macrolide antibiotic with excellent activity against resistant S. pneumoniae and other key\n      typical and atypical bacterial respiratory pathogens. A completed Phase 2 study showed\n      comparable efficacy to levofloxacin in adults with CABP."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male and female patients \u2265 18 years of age\n\n          -  An acute onset of at least 3 of the following signs and symptoms (new or worsening):\n\n        Cough Production of purulent sputum Shortness of breath (dyspnea) Chest pain due to\n        pneumonia\n\n          -  At least 1 of the following:\n\n        Fever Hypothermia Presence of pulmonary rales and/or evidence of pulmonary consolidation\n\n          -  PORT Risk Class II, III, or IV\n\n          -  Presence of lobar, multilobar, or patchy parenchymal infiltrate(s) consistent with\n             acute bacterial pneumonia on a pulmonary imaging study\n\n          -  Not received any systemic antibiotics during the prior 7 days\n\n        Exclusion Criteria:\n\n          -  Ventilator-associated pneumonia\n\n          -  Known anatomical or pathological bronchial obstruction or a history of bronchiectasis\n             or documented severe chronic obstructive pulmonary disease\n\n          -  Hospitalization within 90 days or residence in a long-term care facility within 30\n             days prior to the onset of symptoms\n\n          -  Presence of known:\n\n        Viral or fungal pneumonia Pneumocystis jiroveci pneumonia Aspiration pneumonia Other\n        non-infectious causes of pulmonary infiltrates (e.g. pulmonary embolism, hypersensitivity\n        pneumonia, congestive heart failure) Primary or metastatic lung cancer Cystic fibrosis\n        Active or suspected tuberculosis\n\n          -  Known HIV or myasthenia gravis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "860", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01968733", 
            "org_study_id": "CE01-301"
        }, 
        "intervention": [
            {
                "arm_group_label": "Solithromycin", 
                "intervention_name": "Solithromycin", 
                "intervention_type": "Drug", 
                "other_name": "CEM-101"
            }, 
            {
                "arm_group_label": "Moxifloxacin", 
                "intervention_name": "Moxifloxacin", 
                "intervention_type": "Drug", 
                "other_name": "Avelox"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Moxifloxacin", 
                "Norgestimate, ethinyl estradiol drug combination"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Pneumonia", 
            "CABP", 
            "CAP", 
            "Macrolide"
        ], 
        "lastchanged_date": "May 27, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Little Rock", 
                        "country": "United States", 
                        "state": "Arkansas", 
                        "zip": "72205"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Glendale", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91206"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sylmar", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91342"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Torrance", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90502"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Deland", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32720"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33144"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60611"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Springfield", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "62702"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Council Bluffs", 
                        "country": "United States", 
                        "state": "Iowa", 
                        "zip": "51503"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hazard", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "41701"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Detroit", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48202"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Royal Oak", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48073"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Butte", 
                        "country": "United States", 
                        "state": "Montana", 
                        "zip": "59701"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newark", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "07102"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Somers Point", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "08244"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Johnson City", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "13790"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10003"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Winston-Salem", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27103"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Akron", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44304"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45267"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbus", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "43210"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lima", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45801"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wyomissing", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19610"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rapid City", 
                        "country": "United States", 
                        "state": "South Dakota", 
                        "zip": "57702"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37232"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Winnipeg", 
                        "country": "Canada", 
                        "state": "Manitoba", 
                        "zip": "R3E0J9"
                    }
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Canada"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized, Double-Blind, Multi-Center Study to Evaluate the Efficacy and Safety of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in the Treatment of Adult Patients With Community-Acquired Bacterial Pneumonia", 
        "overall_contact": {
            "email": "dtaylor@cempra.com", 
            "last_name": "David Taylor"
        }, 
        "overall_official": {
            "affiliation": "Cempra Pharmaceuticals", 
            "last_name": "Brian D Jamieson, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To determine noninferiority (NI) in early clinical response rate, in at least 2 of the following 4 cardinal symptoms: cough, shortness of breath, chest pain, and sputum production", 
            "measure": "Early clinical response rate in the Intent to Treat (ITT) population.", 
            "safety_issue": "No", 
            "time_frame": "72 [\u00b112] hours after the first dose of study drug"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01968733"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "To determine NI in early clinical response rate of intravenous to oral solithromycin compared to intravenous to oral moxifloxacin in the mITT population", 
                "measure": "Early clinical response rate in the microITT population", 
                "safety_issue": "No", 
                "time_frame": "72 [\u00b112] hours after the first dose of study drug"
            }, 
            {
                "description": "To determine the overall clinical success rates of intravenous to oral solithromycin compared to moxifloxacin", 
                "measure": "Clinical success rates in the ITT and Clinically Evaluable (CE) populations", 
                "safety_issue": "No", 
                "time_frame": "5 to 10 days after the last dose of study drug"
            }
        ], 
        "source": "Cempra Pharmaceuticals", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cempra Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}